drugset / Trial / NCT01722708

Comparison Between Oral Clindamycin Vs Metronidazole for the Treatment of Abnormal Vaginal Flora in High Risk Pregnancies

NCT01722708

Completed 166 enrolled HaEmek Medical Center, Israel
RandomizedParallel-groupSingle-blindTreatment

Summary

Abnormal vaginal flora is a risk factor for preterm labor. Therefore, in high risk pregnancies for preterm labor the diagnosis and treatment of abnormal flora is indicated. Clindamycin and metronidazole given orally are both acceptable treatments in these cases. The purpose of this study is to compare the effectiveness of Clindamycin Vs metronidazole for the treatment of abnormal vaginal flora in high risk pregnancies. For this purpose, pregnant women who are considered high risk for preterm labor and were diagnosed with abnormal vaginal flora will be randomly treated either with clindamycin or metronidazole. Eradication of the abnormal flora and adverse effects will be monitored and compared

Timeline

Start
2012-11-01
Primary completion
2025-07-02
Completion
2025-12-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Clindamycin Unknown 300 mg Oral
Subject Metronidazole Small molecule 500 mg Oral

Indications